Sign in to tag this notice and share notes on it with your team.
Winston AI writes a plain-English brief of every opportunity — what the buyer wants, and what affects whether to bid. It's free in every Scout workspace. Sign in to see it.
The contract will initially be delivered for NHS-funded care in England, Wales, and publicly funded care in Jersey for a period of 3 years, at a maximum total budget of up to £1,103,361 including VAT, £1,138,669 excluding VAT. Bids exceeding this limit may be rejected. There is the potential to extend this contract for up to 24 months.
All pricing submissions must be in regard to this 'core' value, and not inclusive of any extension costs or aspirational intent costs, i.e. Please only submit a cost schedule up to the maximum core value of £1,103,361 including VAT, £1,138,669 excluding VAT.
The maximum budget ‘core’ value of £1,103,361 including VAT, £1,138,669 excluding VAT excludes the potential two year extension and aspirational intent as described in section 14.4 of Annex A - Service Specification.
Please note, there is no commitment by the Authority at this stage to include any aspirational intent measures. Taking the total of this aspirational intent into account, as well as the possibility that a contract extension may be offered for an additional two years, the potential ceiling value is £6,376,600 GBP including VAT, £5,313,917 GBP excluding VAT.
The role of a national clinical audit is to stimulate healthcare improvement through the provision of high quality information on the organisation, delivery and outcomes of healthcare, together with tools and support to enable healthcare providers and other audiences to make best use of this information. Outcomes are benchmarked against national guidance and standards e.g. quality standards from the National Institute for Health and Care Excellence (NICE), and those from other established professional and patient sources. Successful national audits are those where the individuals providing the data are also in a position to improve the system, and there is a shared understanding of what good care looks like.
The overarching aim is to stimulate improvements in care for children and young people
(CYP) with paediatric diabetes who receive care from Paediatric Diabetes Units (PDUs),
by measuring variations in quality, experience and outcomes of NHS care in England and
Wales, and publicly funded care in Jersey. During this contract period, the successful
tenderer will need to build on the achievements of the audit to date and enhance the
ability for the audit to be used for healthcare improvement.
*The term CYP (Children and Young People) will be used throughout this notice to refer to
children, adolescents and young people up to 24 years (treated within a Paediatric
Diabetes Unit (PDU)).
This audit programme is expected to:
•Develop a robust, high-quality audit designed around 10 key quality metrics likely to best support local and national healthcare quality improvement
| Lot | Title | Value |
|---|---|---|
| 1 | Lot 1 | — |
| Title | Supplier | Value | Awarded |
|---|---|---|---|
| National Paediatric Diabetes Audit | Royal College of Paediatrics and Child Health | £5,313,917 | 7 Jul 2026 |
•Detect, describe and help reduce unwarranted clinical variation by systematically benchmarking performance, identifying outliers, and supporting services to understand variation in outcomes, processes and experience
•Achieve, articulate and maintain close alignment with relevant NICE national guidance and quality standards throughout the audit, as appropriate
•Enable healthcare quality improvement through the provision of timely, high-quality data that compares providers of healthcare, and comprises an integrated mixture of named Trust or Health board, Integrated Care System (ICS), commissioner, multidisciplinary team (MDT), possibly consultant or clinical team level and other levels of reporting
•Be clinically led
•Engage patients, carers and the public in a meaningful way, achieving a strong patient voice which informs and contributes to the design, functioning, outputs and direction of the audit
•Consider the value and feasibility of linking data at an individual patient level to other relevant national datasets either from the outset or in the future, and plan for these linkages from the inception of the contract
•Ensure robust methodological and statistical input at all stages of the audit
•Identify from the outset the full range of audiences for the reports and other audit outputs, and plan and tailor them accordingly
•Provide audit results in a timely, accessible and meaningful manner to support healthcare quality improvement, minimising the reporting delay and providing continual access to each unit for their own data
•Utilise strong and effective project and programme management to deliver audit outputs on time and within budget
•Develop and maintain strong engagement with local clinicians, networks, commissioners, patients, their families and carers as well as charity and community support groups to drive improvements in services.
The anticipated outputs are:
•Quarterly interactive metric results
•Publication of an annual state of the nation report
•Quality improvement resources
•The identification and notification of outliers in line with HQIP and provider policies. The provider shall apply the agreed statistical methodology for outlier detection and identify units, ICBs or health boards that demonstrate performance significantly below expected levels on key NPDA indicators.
•One published spotlight report to be decided by the NPDA dataset and methodology group in conjunction with HQIP and funders
•One published PREM report to be decided by the NPDA dataset and methodology group in conjunction with HQIP and funder
•Hybrid closed loop work in collaboration with NHSE HCL implementation plan
To respond to this opportunity, please visit https://www.delta-esourcing.com/respond/B249J9GYMY